01.06.2018 | Case report
Interleukin 2/vemurafenib
Primary cutaneous small/medium CD4+ T-CELL lymphoproliferative disorder: case report
Erschienen in: Reactions Weekly | Ausgabe 1/2018
Einloggen, um Zugang zu erhaltenExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event